From: Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States
unit: % | ||||
---|---|---|---|---|
Pair | Bacterium (resistant to) → drug | ICU patients | non-ICU inpatients | Outpatients |
A | PAE → Ciprofloxacin/ofloxacin | 32 | 25 | 23 |
B | PAE → Levofloxacin | 37 | 28 | 25 |
C | PAE → Imipenem | 18 | 12 | 9 |
D | PAE → Ceftazidime | 13 | 8 | 5 |
E | PAE → Piperacillin | 16 | 11 | 6 |
F | SAU → Methicillin | 47 | 38 | 23 |
G | Enterococcus spp → Vancomycin | 13 | 11 | 4 |
H | ECO → Cef3* | 1 | 1 | 0 |
I | ECO → Quinolone** | 5 | 4 | 2 |
J | KPN → Cef3 | 6 | 5 | 2 |
K | Enterobacter spp → Cef3 | 26 | 21 | 10 |
L | Enterobacter spp → Carbapenum | 1 | 1 | 1 |
M | CNS → Methicillin | 75 | 63 | 46 |
N | Pneumococcus → Penicillin | 18 | 17 | 17 |
O | Pneumococcus → Cef3 | 7 | 8 | 6 |
Mean | 21 | 17 | 12 |